News
19 March, 2025 - 15:00 (CET)
Announcement
V
On 12 March 2025, the World Health Organization (WHO) prequalified the first maternal respiratory syncytial virus (RSV) vaccine to protect infants against one of the most common causes of acute lower respiratory infections in children globally.